Drug Type Small molecule drug |
Synonyms |
Target |
Mechanism SETD7 inhibitors(SET domain containing 7, histone lysine methyltransferase inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC15H15N3O5S |
InChIKeySIVTXLSKYVOFHS-UHFFFAOYSA-N |
CAS Registry303141-21-1 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Alopecia Areata | Preclinical | CN | 30 Sep 2015 | |
Atherosclerosis | Preclinical | CN | 30 Sep 2015 | |
Diabetes Mellitus | Preclinical | CN | 30 Sep 2015 | |
Hepatitis C | Preclinical | CN | 30 Sep 2015 | |
HIV Infections | Preclinical | CN | 30 Sep 2015 | |
Neoplasms | Preclinical | CN | 30 Sep 2015 |